Insulin glargine (Tianmai Biotechnology)

In healthy Chinese subjects, the normal glucose clamp technique was used to conduct human pharmacokinetics and pharmacodynamics studies of recombinant insulin glargine injection and insulin glargine injection (Lantus) to evaluate the bioavailability and bioequivalence of the two drugs, and the safety and tolerability of recombinant insulin glargine injection were also evaluated.